We are a new kind of biotech company

Discovery
Synergistic
Complementary

Meet The Team

Our team pairs drug discovery and financial strategists for an innovative biotechnology startup model that puts scientists and patients first.

team
Hemanta Baruah  
Founder & CEO

An experienced drug developer with an approved checkpoint inhibitor and several additional candidates in advanced clinical trials.

team
Errik Anderson  
Board Member

Founder and CEO of Alloy Therapeutics. Serial biotech scientist entrepreneur including co-founding Adimab, Alector, Arsanis, Avitide, and Compass Therapeutics.

team
Chris Pacheco, PhD  
Board Member

Executive Partner at 82VS, Alloy Therapeutics’ affiliated venture studio. Formerly, Chris was at Polaris Partners, Roche Diagnostics, and the Whitehead Institute.

team
Robert Mabry, PhD  
Board Member

CSO at Orna Therapeutics. Formerly, Robert was at Takeda Pharmaceuticals, Cogen Therapeutics (Repertoire Immune Medicines), Jounce Therapeutics, and Adimab.

team
Manoj Sabnani  
Scientist

Associate scientist at Alloy Therapeutics, previously lab coordinator at University of Texas Arlington and researcher at Texas Tech University Health Sciences Center and Purdue University Calumet.

team
Taylor Gray, PhD  
Scientist

University of Chicago PhD with a focus on tumor microenvironment for cancer immunotherapy, previously a predoctoral researcher at Adimab.

A Special Partnership

Incubated in Alloy Therapeutics’ affiliated venture studio, Aakha.bio was created through a collaborative partnership model that leverages access to Alloy’s ATX-Gx™ transgenic mouse, suite of antibody discovery platforms, and discovery services.

Alloy Therapeutics

If you are a drug hunter looking to join a focused and energized team, please connect with us

[email protected]